Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-25

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution for lowering intraocular pressure in open-angle glaucoma or ocular hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution (Dorzolamide hydrochloride and timolol maleate)

Snippet

ORIG AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)